Session Details

Multiple Sclerosis

Thursday, 15 May 2003 14:30 -17:30

Auditorium

Sponsored by: Serono

Convenor John King The Departments of Clinical Neurosciences and Medicine, 
Co-Chair John D Pollard   
Co-Chair John King The Departments of Clinical Neurosciences and Medicine, 
Non Responders and Treatment Failures
  • Professor John Noseworthy, Mayo Clinic, United States
    • NAB- The Westmead Project
  • Dr Robert Heard
    • Interferon Beta in MS: The Effect of Antibody Development on Outcomes
  • Dr John King, The Departments of Clinical Neurosciences and Medicine,
    • Mitoxanthrone in MS
  • Dr Helmut Butzkueven, The Royal Melbourne Hospital-department of neurology
    • Update on Australian MS Longitudinal Study
  • Dr Rex Simmons